Literature DB >> 30908282

What's New in Intra-Arterial Chemotherapy for Retinoblastoma?

David H Abramson, Jasmine H Francis, Yves Pierre Gobin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30908282     DOI： 10.1097/IIO.0000000000000266

Source DB:  PubMed          Journal:  Int Ophthalmol Clin        ISSN： 0020-8167


× No keyword cloud information.
  4 in total

1.  Retinoblastoma management in 13q deletion syndrome patients using super-selective chemotherapies and other cancer-directed interventions.

Authors:  Lucy V Cobbs; Jasmine H Francis; Ira J Dunkel; Y Pierre Gobin; Scott E Brodie; David H Abramson
Journal:  Pediatr Blood Cancer       Date:  2020-12-23       Impact factor: 3.838

2.  Cell-free DNA profiling in retinoblastoma patients with advanced intraocular disease: An MSKCC experience.

Authors:  Prachi Kothari; Francesco Marass; Julie L Yang; Caitlin M Stewart; Dennis Stephens; Juber Patel; Maysun Hasan; Xiaohong Jing; Fanli Meng; Jeanette Enriquez; Kety Huberman; Agnes Viale; Jasmine H Francis; Michael F Berger; Neerav Shukla; David H Abramson; Ira J Dunkel; Dana W Y Tsui
Journal:  Cancer Med       Date:  2020-07-07       Impact factor: 4.452

Review 3.  Intra-arterial chemotherapy in retinoblastoma - A paradigm change.

Authors:  Fairooz P Manjandavida; Christina Stathopoulos; Jing Zhang; Santhosh G Honavar; Carol L Shields
Journal:  Indian J Ophthalmol       Date:  2019-06       Impact factor: 1.848

4.  A decision process for drug discovery in retinoblastoma.

Authors:  María Belen Cancela; Santiago Zugbi; Ursula Winter; Ana Laura Martinez; Claudia Sampor; Mariana Sgroi; Jasmine H Francis; Ralph Garippa; David H Abramson; Guillermo Chantada; Paula Schaiquevich
Journal:  Invest New Drugs       Date:  2020-11-16       Impact factor: 3.850
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.